Status:
COMPLETED
Spectroscopy in Ovarian Cancer
Lead Sponsor:
University of Exeter
Collaborating Sponsors:
University Hospitals Bristol and Weston NHS Foundation Trust
Conditions:
Ovarian Cancer
Ovarian Neoplasms
Eligibility:
FEMALE
18+ years
Brief Summary
Ovarian cancer is the eighth most common cause of cancer death in the world. Advanced stage at diagnosis is associated with lower survival rates, thus early detection appears to have an important role...
Eligibility Criteria
Inclusion
- Female
- Symptoms suggestive of ovarian cancer
- Patients undergoing treatment of Ovarian Cancer
Exclusion
- Less than 18 years of age
- Unable to consent to the study due to communication difficulties
- Unable to consent to the study due to lack of capacity
Key Trial Info
Start Date :
June 28 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04817449
Start Date
June 28 2021
End Date
October 30 2025
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Bristol and Weston NHS Trust
Bristol, United Kingdom